BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10227266)

  • 1. Effect of long-term treatment with inhaled beclomethasone dipropionate on growth of asthmatic children.
    Inoue T; Doi S; Takamatsu I; Murayama N; Kameda M; Toyoshima K
    J Asthma; 1999; 36(2):159-64. PubMed ID: 10227266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of inhaled beclomethasone on height growth and bone metabolism in children with asthma].
    Inoue T; Doi S; Takamatsu I; Murayama N; Kameda M; Hayashida M; Nishida M; Toyoshima K
    Arerugi; 1995 Jul; 44(7):678-84. PubMed ID: 7575133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of double-strength beclomethasone dipropionate (84 microg) MDI with beclomethasone dipropionate (42 microg) MDI in the treatment of asthma.
    Nathan RA; Nolop KB; Cuss FM; Lorber RR
    Chest; 1997 Jul; 112(1):34-9. PubMed ID: 9228354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
    Pedersen S; Warner J; Wahn U; Staab D; Le Bourgeois M; Van Essen-Zandvliet E; Arora S; Szefler SJ;
    Pediatrics; 2002 Jun; 109(6):e92. PubMed ID: 12042586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systemic side effects of long-term treatment with low dose inhaled corticosteroids in children with asthma].
    Chen A; Chen R; Zhong N
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Dec; 24(12):740-3. PubMed ID: 11930704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women.
    Fujita K; Kasayama S; Hashimoto J; Nagasaka Y; Nakano N; Morimoto Y; Barnes PJ; Miyatake A
    J Bone Miner Res; 2001 Apr; 16(4):782-7. PubMed ID: 11316007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
    Wolthers OD; Walters EG
    Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial improvements in lung function and bronchial hyperresponsiveness are maintained during 5 years of treatment with inhaled beclomethasone dipropionate and terbutaline.
    Douma WR; Kerstjens HA; de Gooijer A; Overbeek SE; Koëter GH; Postma DS;
    Chest; 2002 Jan; 121(1):151-7. PubMed ID: 11796444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients.
    Singh D; Piccinno A; Borrill Z; Poli G; Acerbi D; Meuleners L; Woodcock A
    Pulm Pharmacol Ther; 2008; 21(3):551-7. PubMed ID: 18321744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term growth and adrenal function in children with asthma treated with inhaled beclomethasone dipropionate hydrofluoroalkane-134a.
    Wolthers OD
    Pediatr Allergy Immunol; 2006 Dec; 17(8):613-9. PubMed ID: 17121590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of beclomethasone and factors related to asthma on the growth of prepubertal children.
    Camargos PA; Lasmar LM
    Respir Med; 2010 Jul; 104(7):951-6. PubMed ID: 20189373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled beclomethasone dipropionate and growth in children with mild asthma.
    Turpeinen M; Sorva R
    Am J Respir Crit Care Med; 1996 May; 153(5):1726. PubMed ID: 8630627
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth of asthmatic children is slower during than before treatment with inhaled glucocorticoids.
    Saha MT; Laippala P; Lenko HL
    Acta Paediatr; 1997 Feb; 86(2):138-42. PubMed ID: 9055881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial.
    Szefler SJ; Warner J; Staab D; Wahn U; Le Bourgeois M; van Essen-Zandvliet EE; Arora S; Pedersen S;
    J Allergy Clin Immunol; 2002 Jul; 110(1):45-50. PubMed ID: 12110818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal evaluation of bone mass in asthmatic children treated with inhaled beclomethasone dipropionate or cromolyn sodium.
    Martinati LC; Bertoldo F; Gasperi E; Fortunati P; Lo Cascio V; Boner AL
    Allergy; 1998 Jul; 53(7):705-8. PubMed ID: 9700040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beclomethasone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma.
    Terzano C; Allegra L; Barkai L; Cremonesi G
    Eur Rev Med Pharmacol Sci; 2001; 5(1):17-24. PubMed ID: 11860218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.
    Wolthers OD; Moore A; Mersmann S; Dissanayake S
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):373-380. PubMed ID: 28510491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year trial on safety and normal linear growth with flunisolide HFA in children with asthma.
    Gillman SA; Anolik R; Schenkel E; Newman K
    Clin Pediatr (Phila); 2002 Jun; 41(5):333-40. PubMed ID: 12086199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy.
    Maspero JF; Dueñas-Meza E; Volovitz B; Pinacho Daza C; Kosa L; Vrijens F; Leff JA
    Curr Med Res Opin; 2001; 17(2):96-104. PubMed ID: 11759189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of changing from chlorofluorocarbon (CFC)-beclomethasone dipropionate (BDP) to hydrofluoroalkane (HFA)-BDP on pulmonary function in asthmatic children].
    Yoshida Y; Inoue T; Nishikido T; Kameda M; Takamatu I; Doi S
    Arerugi; 2007 Dec; 56(12):1502-9. PubMed ID: 18195554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.